Leuko
leuko.ioLocations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
Size
11-50 employees
founded in
2017
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically relevant situations, ranging from chemotherapy management to the detection of life-threatening infections worldwide. This test is currently invasive and not readily accessible; it requires patient travel, blood draws, and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
Something looks off?Open jobs at Leuko
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.